Skip to content
  • Anxiety and sensory sensitivity in autism and ADHD

    Anxiety and sensory sensitivity in autism and ADHD

    Part 4 of the article series on the Biomarker Workshop 2025 86% of autistic adults report daily problems with anxiety. This figure shows that anxiety in autism is not the exception but a central part of the experience. Anxiety disorders in autism: the figures Research by Zaboski et al. (2018) documents the various anxiety disorders…

    November 28, 2025
  • Camouflaging – the exhausting art of masking

    Camouflaging – the exhausting art of masking

    Part 3 of the article series on the Biomarker Workshop 2025 “I can dance. I can dance with anyone who wants to dance with me, but it is always their choreography.” This quote aptly describes what many autistic people – especially women – experience every day: they have learned to adapt, to follow social rules…

    November 28, 2025
  • ADHD in women and girls – the invisible challenge

    ADHD in women and girls – the invisible challenge

    Part 2 of the article series on the Biomarker Workshop 2025 ADHD in girls and women often goes unrecognised for years. Unlike boys, who more often stand out through hyperactive and impulsive behaviour, girls show subtler symptoms – and are therefore systematically overlooked. Early signs: the daily struggle begins According to Attwood and Garnett, many…

    November 28, 2025
  • AuDHD – when autism and ADHD meet

    AuDHD – when autism and ADHD meet

    Insights from 80 years of clinical practice by Prof. Tony Attwood and Dr Michelle Garnett Part 1 of the article series on the Biomarker Workshop 2025 For a long time, autism and ADHD were regarded as mutually exclusive diagnoses. Only with the DSM-5 revision in 2013 was it recognised what those affected and experienced clinicians…

    November 28, 2025
  • When subjective experience and objective measurement complement each other

    When subjective experience and objective measurement complement each other

    Integrating neurobiological diagnostics in child and adolescent psychiatry – a unifying approach for ADHD, autism, anxiety disorders and hypersensitivity A bridge-builder between worlds Dr. med. Birgit Graf, specialist in child and adolescent psychiatry and psychotherapy, embodies an approach that connects rather than divides. As medical director of BrainARC-Ostschweiz, she has for years successfully integrated the…

    November 23, 2025
  • Between worlds: Matthias Huber and the therapeutic power of lived experience

    The bridge-builder who understands both sides Whenever Matthias Huber leaves his house, he always carries a cap, noise-cancelling headphones and sunglasses. Not for reasons of fashion, but as a shield against a world that is often overwhelming for him. Stimuli that other people barely notice can feel like electric shocks to the 56-year-old psychologist. Matthias…

    November 21, 2025
  • Dimensional diagnostics: why we should diagnose patterns rather than pigeonholes

    Dimensional diagnostics: why we should diagnose patterns rather than pigeonholes

    Psychiatric diagnostics is facing a paradigm shift. While for decades we have tried to fit our patients into clearly delineated diagnostic categories – ADHD, autism, anxiety disorder, hypersensitivity – current research paints a completely different picture: these conditions overlap massively. The sharp boundaries suggested by our diagnostic manuals do not exist in reality. What we…

    November 17, 2025
  • BrainARC Zürich: where brain function and clinical expertise meet

    BrainARC Zürich: where brain function and clinical expertise meet

    Neurobiological precision in clinical practice: Dr Corinne Henzen and the integration of objective markers BrainARC Zürich occupies a special position in Switzerland’s psychiatric care landscape. The competence centre, with 14 highly qualified specialists from psychology, neuropsychology, medicine and administration, is consistently committed to an integrative approach: combining traditional clinical expertise with objective neurobiological measurements. This…

    November 15, 2025
  • How Skopje and the GTSG are making the biological basis of autism more objectively diagnosable

    How Skopje and the GTSG are making the biological basis of autism more objectively diagnosable

    Scientific excellence meets clinical implementation When Prof. Dr Silvana Markovska-Simoska and Dr Aleksandar Tenev present their talk “Neurophysiological Recognition and Its Implementation in Clinical Practice” at the 14th Biomarker Workshop in Zurich on 11 December 2025, they will demonstrate more than research findings: they will show how objective biomarker diagnostics for autism is moving from…

    November 8, 2025
  • When demands become a threat: understanding PDA within the autism spectrum

    When demands become a threat: understanding PDA within the autism spectrum

    Imagine a child who desperately wants to go to school but cannot. Who loves their family and wants to hug them, but freezes when touched in a way they have not chosen. Who knows exactly how to put on shoes, but whose body refuses to carry out this simple action. What at first glance looks…

    November 2, 2025
  • Beyond the Stereotypes: why Tony Attwood and Michelle Garnett are speaking at the Biomarker Workshop 2025

    Beyond the Stereotypes: why Tony Attwood and Michelle Garnett are speaking at the Biomarker Workshop 2025

    Attwood and Garnett speak at the Biomarker Workshop 2025

    October 28, 2025
  • Manifesto for integrating brain function analysis into psychiatric diagnostics

    Manifesto for integrating brain function analysis into psychiatric diagnostics

    Preamble: from either-or medicine to both-and medicine Modern psychiatry is at a turning point. With more than 970 million people worldwide affected by mental disorders, and diagnostic agreement rates for major depression reaching kappa values of just 0.28–0.32, it is time to expand our diagnostic tools. Brain function analysis (BFA) is not a competitor to…

    October 22, 2025
  • The economic costs of diagnostic inaccuracy: Why objective biomarkers represent an investment in the future

    The economic costs of diagnostic inaccuracy: Why objective biomarkers represent an investment in the future

    The scientific evidence for the superiority of neurobiological biomarkers over subjective diagnostic methods is supported by a convincing health economic analysis that highlights the hidden costs of current diagnostic inaccuracy. The hidden cost burden of incorrect diagnoses The systematic reliability problems of psychiatric diagnostics lead to enormous, often invisible costs in the healthcare system. If…

    October 13, 2025
  • Precision medicine through EEG-based vigilance profiles: Individual attention patterns in children

    Precision medicine through EEG-based vigilance profiles: Individual attention patterns in children

    Challenges resulting from cognitive load or mental overload may require adjustments to the task structure, for example by dividing it into smaller units or incorporating regular breaks. However, the study also has limitations, in particular the moderate variance explanation of R² = 0.2, which could limit the application of the model to assign individuals to…

    October 12, 2025
  • From subjective to subjective-objective: Why biomarkers are revolutionizing psychiatric diagnostics

    From subjective to subjective-objective: Why biomarkers are revolutionizing psychiatric diagnostics

    The silent challenge of modern psychiatry Over 970 million people worldwide are affected by mental disorders, yet in 2025 psychiatric diagnosis will still be based primarily on subjective symptom assessments and clinical interviews. This reality may come as a surprise, given the exponential advances in neuroscience in recent decades. A comprehensive systematic analysis of the…

    October 6, 2025
  • Interrater-Reliabilität in der Psychiatrie: Quantitative Evidenz für systematische Diagnostikfehler

    Interrater-Reliabilität in der Psychiatrie: Quantitative Evidenz für systematische Diagnostikfehler

    Abstract Hintergrund: Die Zuverlässigkeit psychiatrischer Diagnosen zwischen verschiedenen Beurteilern ist ein kritischer Qualitätsindikator für die diagnostische Validität. Diese Übersichtsarbeit analysiert quantitative Daten zur Interrater-Reliabilität häufiger psychiatrischer Störungen. Methodik: Systematische Literaturauswertung von Meta-Analysen, DSM-5 Field Trials und Originalstudien zu Kappa-Statistiken bei psychiatrischen Diagnosen. Ergebnisse: Die DSM-5 Field Trials zeigen ernüchternde Reliabilitätswerte für häufige Störungen. Major Depression…

    September 28, 2025
  • Neurobiologische Überlappungen zwischen ADHS, Autismus und Angststörungen: Eine evidenzbasierte Übersicht

    Neurobiologische Überlappungen zwischen ADHS, Autismus und Angststörungen: Eine evidenzbasierte Übersicht

    Einleitung Die diagnostischen Grenzen zwischen Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS), Autismus-Spektrum-Störungen (ASS) und Angststörungen erweisen sich in der klinischen Praxis und Forschung zunehmend als unscharf. Diese Überlappungen stellen sowohl für die Diagnostik als auch für die Therapieplanung eine erhebliche Herausforderung dar. Der vorliegende Beitrag fasst gesicherte Erkenntnisse zu den neurobiologischen Gemeinsamkeiten und Unterschieden dieser Störungsbilder zusammen. Die…

    September 23, 2025
  • Die verborgene Symphonie des Gehirns: Wie Microstates unsere Gedankenwelt orchestrieren

    Die verborgene Symphonie des Gehirns: Wie Microstates unsere Gedankenwelt orchestrieren

    Wenn Millisekunden über unser Denken entscheiden Stellen Sie sich vor, Ihr Gehirn wäre ein gigantisches Orchester mit 86 Milliarden Musikern – den Neuronen. Doch statt einem chaotischen Durcheinander erklingt eine präzise koordinierte Symphonie. Die Dirigenten dieser neuronalen Symphonie sind winzige elektrische Muster, die nur 60 bis 120 Millisekunden andauern: die EEG-Microstates, auch als “Atome des…

    September 18, 2025
  • ADHD-Autism-Anxiety-Hypersensitivity

    ADHD-Autism-Anxiety-Hypersensitivity

    September 7, 2025
  • Biomarker Workshop 2025:

    Biomarker Workshop 2025:

    Date: December 11, 2025, 9:00 a.m. to 12:30 p.m. and 1:30 p.m. to 5:30 p.m. Location: Zurich Format: Hybrid. Limited number of seats available on site/online via Zoom Cost: $150 Since 2006, the Brain and Trauma Foundation Graubünden/Switzerland (GTSG) has been committed to application-oriented research that directly benefits people, in particular through the development of…

    August 31, 2025
←Previous Page
1 2 3 4 5 … 8
Next Page→

Kontakt

Gehirn- und Traumastiftung Graubünden
Schulstrasse 1
CH-7302 Landquart

Telefon: +41 81 322 28 28
E-Mail: info@gtsg.ch

Newsletter

Bleiben Sie informiert über unsere Workshops, Forschung und Neuigkeiten.

Zum Newsletter

Rechtliches

Impressum
Datenschutz · Privacy
Kontaktformular
Jahresberichte

Contact

Brain and Trauma Foundation Grison
Schulstrasse 1
CH-7302 Landquart, Switzerland

Phone: +41 81 322 28 28
Email: info@gtsg.ch

Newsletter

Stay informed about our workshops, research and news.

Subscribe

Legal

Imprint
Privacy Policy · Datenschutz (DE)
Contact form
Annual reports


  • LinkedIn
  • Facebook
Newsletter – Jetzt anmelden